Vx Pharma endorses the principle of Good Clinical Practice (GCP) with regards human subject protection (HSP) as regulated by the U.S. Food and Drug Administration (FDA). Not only do our fulltime research teams adhere to international quality standards, but when it comes to the way trials are conducted and in the standard of care delivered, Vx Pharma selects their business and research partners on the merit of high ethical performance. At all times, our prime consideration is to execute good quality services without compromising the standard of care of patients.
Vx Pharma respects the dignity and rights of trial participants and is committed to safeguarding their well-being. Hence, all our clinical trial proposals for new medical entities are reviewed by a central ethics committee for approval by the Medicines Control Council (MCC), a statutory body that regulates the safety and efficacy of medicines and medical devices in South Africa.